Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$4.25K Hold
57
﹤0.01% 961
2025
Q3
$3.85K Buy
+57
New +$3.78K ﹤0.01% 955
2024
Q1
Sell
-1
Closed -$71 871
2023
Q4
$71 Buy
+1
New +$70 ﹤0.01% 794
2023
Q3
Sell
-94
Closed -$7.61K 830
2023
Q2
$7.61K Hold
94
﹤0.01% 699
2023
Q1
$7.59K Hold
94
﹤0.01% 741
2022
Q4
$7.03K Hold
94
﹤0.01% 737
2022
Q3
$6K Sell
94
-75
-44% -$5.2K ﹤0.01% 806
2022
Q2
$12K Buy
+169
New +$12.5K ﹤0.01% 652
2022
Q1
Sell
-75
Closed -$6K 501
2021
Q4
$6K Buy
+75
New +$5.51K ﹤0.01% 712
2021
Q3
Sell
-75
Closed -$5K 487
2021
Q2
$5K Buy
+75
New +$5.01K ﹤0.01% 693
2018
Q4
Sell
-115
Closed -$5K 1005
2018
Q3
$5K Hold
115
﹤0.01% 911
2018
Q2
$5K Buy
+115
New +$4.42K ﹤0.01% 940

Other funds holding HOLX

Trust Company of Vermont's HOLX Position: Q4 2025 in Review

Trust Company of Vermont held its Hologic (HOLX) position steady in Q4 2025 at 57 shares worth $4.25K. The position accounts for ﹤0.01% of the portfolio, ranked #961.

Trust Company of Vermont first reported a position in HOLX in Q2 2018 and has held it in 12 quarters since. The position peaked at $12K in Q2 2022. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

  • Trust Company of Vermont held 57 shares of Hologic worth $4.25K as of Q4 2025.
  • Trust Company of Vermont left its Hologic share count unchanged in Q4 2025.
  • Hologic made up ﹤0.01% of Trust Company of Vermont's portfolio in Q4 2025, its #961 holding.
  • Trust Company of Vermont first reported a position in Hologic in Q2 2018 and has held it in 12 quarters since.
  • Trust Company of Vermont's Hologic position peaked at $12K in Q2 2022.
  • 749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.